Home | Welcome to Contract Pharma   
Last Updated Monday, December 22 2014

Print

Breaking News

Related Searches:
June 18, 2010
Haupt Pharma Amareg has opened several new purpose-built laboratories for pharmaceutical development, increasing its capacity for analytical development projects.  Read More »
June 17, 2010
Catalent Pharma Solutions has joined the Business Ethics Leadership Alliance (BELA), a new initiative founded by The Ethisphere Institute to promote ethical business practices.  Read More »
June 17, 2010
Bayer Schering Pharma and OncoMed Pharmaceuticals entered into a global strategic alliance to discover, develop and commercialize anti-cancer stem cell therapeutics targeting the Wnt signaling pathway.  Read More »
June 17, 2010
EMD Serono, Inc., an affiliate of Merck KGaA, is resuming its Stimuvax (BLP25 liposome vaccine) clinical program in patients with non-small cell lung cancer (NSCLC), which includes a pair of Phase III studies.  Read More »
June 17, 2010
Evotec AG has received a $3.1 million milestone payment through its research alliance with Boehringer Ingelheim.   Read More »
June 16, 2010
After acquiring Hyaluron, where is AMRI headed?  Read More »
June 16, 2010
$75 million upfront for post-IIb oral hormone antagonist  Read More »
June 16, 2010
New CIO at CRO  Read More »
June 16, 2010
Solvay veteran to help ZENPEP launch  Read More »
June 16, 2010
Transgenics company shrinks to survive  Read More »
June 15, 2010
Sacheting expansion sponsored by client need  Read More »
June 15, 2010
MS Drug currently in two Phase III trials against Rebif  Read More »
June 15, 2010
$27 million buy adds prefilled syringe capacity to AMRI offerings  Read More »
June 14, 2010
Movement atop Softgels, other Catalent units  Read More »
June 14, 2010
Bayer, Onyx drug shows no survival improvement in study  Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On